Importantly, therapeutic agents such as angiotensin receptor blockers (ARBs) and ACE inhibitors (ACEIs), which upregulate ACE2 expression, have been hypothesized to potentially increase susceptibility to SARS-CoV-2 by enhancing viral entry into host cells, thereby raising concerns about their use during active infection [31]. The gene discussed is ACE2; the disease is infection.